Aller au contenu principal

Découvrez nos professeurs et professeures!

Darren Edward Richard

Professeur titulaire

Darren Edward Richard
Centre de recherche sur le cancer
Centre de recherche du CHU de Québec - Université Laval
Partager la fiche :

Contribution à la recherche

Thématiques de recherche de la Faculté de médecine

  • Oncologie
  • Santé cardiovasculaire, respiratoire et métabolisme

Projets de recherche en cours

  • Hydrochlorothiazide and accelerated CKD-related vascular calcification - Fondation canadienne du rein - Subventions de recherche en santé des reins, co-chercheur - 2023-07-01 au 2025-06-30

Financements des 2 dernières années

  • Novel Interactions and Functions for Hypoxia-Inducible Factor-1 (HIF-1) during Vascular Responses - Fondation de l'Université Laval, chercheur principal - 2016-04-01 au 2022-03-31

Publications

  • Identification of alternative spliced variants of human hypoxia- inducible factor-1α, Pouysségur, J., Pagès, G., Berra, E., Richard, D.E., Gothié, E., Journal of Biological Chemistry, 2000, 10.1074/jbc.275.10.6922
  • HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism, Bonnet, S., Richard, D.E., Robitaille, G.A., Roy, M., Lambert, C.M., Cardiovascular Research, 2010, 10.1093/cvr/cvq152
  • Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells, Richard, D.E., Michaud, M.D., Pagé, E.L., Lauzier, M.-C., Endocrinology, 2007, 10.1210/en.2007-0285
  • Sphingosine-1-phosphate: A novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells, Richard, D.E., Gratton, J.-P., Robitaille, G.A., Michaud, M.D., Arteriosclerosis, Thrombosis, and Vascular Biology, 2009, 10.1161/ATVBAHA.109.185280
  • Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells, Richard, D.E., Leduc, R., Laporte, S.A., Guillemette, G., Bernier, S.G., Endocrinology, 1997, 10.1210/en.138.9.3828
  • Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway, Guillemette, G., Caron, M., Chrétien, L., Richard, D.E., Molecular and Cellular Endocrinology, 1997, 10.1016/S0303-7207(97)00065-8
  • HIF-1 activation during tumor progression: Implications and consequences | Activation de HIF1 dans le cancer: Implications et conséquences, Richard, D.E., Michaud, M.D., Lauzier, M.-C., Déry, M.-A.C., Bulletin du Cancer, 2006
  • Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells., Guillemette, G., Leduc, R., Bernier, S.G., Laporte, S.A., Richard, D.E., Endocrinology, 1997
  • Angiogenesis: How a tumor adapts to hypoxia, Pouysségur, J., Berra, E., Richard, D.E., Biochemical and Biophysical Research Communications, 1999, 10.1006/bbrc.1999.1889
  • Adenoviral protein E4orf4 interacts with the polarity protein Par3 to induce nuclear rupture and tumor cell death, Josée N. Lavoie, Marc-Étienne Huot, François Bordeleau, Darren E. Richard, Patrick Laprise, Herman Lambert, Margit Fuchs, Jonathan Bergeman, Marie-Chloé Boulanger, Kévin Jacquet, Alexia Caillier, Marc-Antoine Rodrigue, Claire Dziengelewski, Journal of Cell Biology, 2020, 10.1083/jcb.201805122
  • Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells, Pouyssegur, J., Berra, E., Richard, D.E., Journal of Biological Chemistry, 2000, 10.1074/jbc.M003325200
  • Hypoxia-inducible factor-1α (HIF-1 escapes O2-driven proteasomal degradation irrespective of its subcellular localization: Nucleus or cytoplasm, Pouysségur, J., Richard, D.E., Roux, D., Berra, E., EMBO Reports, 2001, 10.1093/embo-reports/kve130
  • Desensitization of AT1receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells, Guillemette, G., Leduc, R., Bernier, S.G., Laporte, S.A., Richard, D.E., Endocrinology, 1997, 10.1210/endo.138.9.5409
  • Hypoxia-inducible factor-1 activation in nonhypoxic conditions: The essential role of mitochondrial-derived reactive oxygen species, Richard, D.E., Giaccia, A.J., Chan, D.A., Robitaille, G.A., Lafleur, V.N., Patten, D.A., Molecular Biology of the Cell, 2010, 10.1091/mbc.E10-01-0025
  • Transforming growth factor β1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression, Dubois, C.M., Richard, D.E., Charbonneau, M., Grandmont, S., McMahon, S., Journal of Biological Chemistry, 2006, 10.1074/jbc.M604507200
  • Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators, Richard, D.E., Michaud, M.D., Déry, M.-A.C., International Journal of Biochemistry and Cell Biology, 2005, 10.1016/j.biocel.2004.08.012
  • Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state, Guillemettes, G., Richard, D.E., Chrétien, L., Boulay, G., Endocrinology, 1994, 10.1210/endo.135.5.7956936
  • Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification, Richard, D.E., Larivière, R., Mokas, S., Ung, R.-V., Gautier-Bastien, A., St-Louis, R., Agharazii, M., American Journal of Hypertension, 2015, 10.1093/ajh/hpu225
  • The organization of the suprachiasmatic circadian pacemaker of the rat and its regulation by neurotransmitters and modulators., Tcheng, T.K., Richard, D., Medanic, M., McArthur, A.J., Liu, C., Faiman, L.E., Gallman, E.A., Ding, J.M., DeMarco, S.J., Gillette, M.U., 1993
  • Angiogenesis and G-protein-coupled receptors: Signals that bridge the gap, Pouysségur, J., Vouret-Craviari, V., Richard, D.E., Oncogene, 2001, 10.1038/sj.onc.1204193
  • TGFβ-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration, Lebrun, J.-J., Richard, D.E., Laporte, S.A., Sontag, T., Mancini, J., Ho, J., Chen, H., Guo, J., Cellular Signalling, 2009, 10.1016/j.cellsig.2009.01.037
  • The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization, Servant, G., Richard, D.E., Leduc, R., Laporte, S.A., Guillemette, G., Escher, E., Molecular Pharmacology, 1996
  • Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II, Sidibé, A., Richard, D.E., Poitras, M., Guillemette, G., Chrétien, L., Receptors and Channels, 1998
  • Bovine adrenal glomerulosa cells express such a low level of functional B2 receptors that bradykinin does not significantly increase their aldosterone production, Guillemette, G., Paitras, M., Poirier, S.N., Richard, D.E., Chrétien, L., Journal of Endocrinology, 1998, 10.1677/joe.0.1560449
  • Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: Conformational and biological implications, Marshall, G.R., Escher, E., Richard, D.E., Pérodin, J., Nikiforovich, G.V., Zhang, W.-J., Journal of Medicinal Chemistry, 1996, 10.1021/jm9507744
  • The Werner syndrome gene product (WRN): A repressor of hypoxia-inducible factor-1 activity, Richard, D.E., Lebel, M., Lamalice, L., Garand, C., Robitaille, G.A., Patten, D.A., Lafleur, V.N., Labbé, A., Experimental Cell Research, 2012, 10.1016/j.yexcr.2012.04.010
  • Signaling angiogenesis via p42/p44 MAP kinase and hypoxia, Pouysségur, J., Pagès, G., Roux, D., Gothié, E., Viñals, F., Le Gall, M., Richard, D.E., Milanini, J., Berra, E., Biochemical Pharmacology, 2000, 10.1016/S0006-2952(00)00423-8
  • The adenoviral protein E4orf4: a probing tool to decipher mechanical stress-induced nuclear envelope remodeling in tumor cells, Josée N. Lavoie, Darren E. Richard, Marc-Antoine Rodrigue, Kévin Jacquet, Cell Cycle, 2020, 10.1080/15384101.2020.1836441
  • HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1α degradation, Pouysségur, J., Gothié, E., Richard, D.E., Berra, E., FEBS Letters, 2001, 10.1016/S0014-5793(01)02159-7
  • Selective HIF-1 regulation under nonhypoxic conditions by the p42/p44 MAP kinase inhibitor PD184161, Richard, D.E., Lamalice, L., Turgeon, C.A., Mokas, S., Jalouli, M., Molecular Pharmacology, 2017, 10.1124/mol.117.108654
  • Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state, Richard, D.E., Guillemette, G., Chrétien, L., Boulay, G., Endocrinology, 1994, 10.1210/en.135.5.2130
  • Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins, Dubois, C.M., Richard, D.E., McDonald, P.P., Grondin, F., McMahon, S., Journal of Biological Chemistry, 2005, 10.1074/jbc.M413248200
  • HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism, Bonnet, S., Richard, D.E., Robitaille, G.A., Roy, M., Lambert, C.M., Continuing Education in Anaesthesia, Critical Care and Pain, 2010
  • Selective interaction of chemical dyes with inositol 1,4,5-trisphosphate recognition sites, Richard, D.E., Guillemette, G., Boulay, G., Bernier, S., Canadian Journal of Physiology and Pharmacology, 1994
  • Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF, Brahimi-Horn, M.C., Pouysségur, J., Déry, M.-A., Richard, D.E., Hattab, M., Trottier, E., Mazure, N., Bilton, R., Journal of Biological Chemistry, 2005, 10.1074/jbc.M504482200
  • Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases, Bonnet, S., Richard, D.E., Agharazii, M., Robitaille, G.A., Meloche, J., Roy, M., Lambert, C.M., American Journal of Physiology - Heart and Circulatory Physiology, 2010, 10.1152/ajpheart.00562.2010
  • Erratum: Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF (Journal of Biological Chemistry (2005) 280 (31132-31140)), Trottier, E., Richard, D.E., Pouysségur, J., Mazure, N., Hattab, M., Déry, M.-A., Brahimi-Horn, M.C., Bilton, R., Journal of Biological Chemistry, 2006
  • The prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity, Richard, D.E., Lu, K.P., Zhou, X.Z., Lamalice, L., Lafleur, V.N., Déry, M.A.C., Jalouli, M., 2014, 10.1016/j.cellsig.2014.04.005
  • Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1α, Richard, D.E., Soucy, G.M., Pagé, E.L., Blouin, C.C., Blood, 2004, 10.1182/blood-2003-07-2427
  • Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms, Richard, D.E., Pouysségur, J., Robitaille, G.A., Pagé, E.L., Journal of Biological Chemistry, 2002, 10.1074/jbc.M209114200
  • The high affinity state of inositol 1,4,5-trisphosphate receptor is a functional state, Servant, M., Richard, D.E., Poitras, M., Guillemette, G., Boulay, G., Bernier, S., Journal of Biological Chemistry, 1993
  • Effects of TGF-β1 on endothelial factors, Lebel, M., Larivire, R., Richard, D.E., Robitaille, G.A., Midaoui, A.E., Cellier, E., Archives of Physiology and Biochemistry, 2010, 10.3109/13813451003610862
  • Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels, Jean-François Côté, Jean-Philippe Gratton, Morag Park, Darren E. Richard, William J. Muller, Carla V. Rothlin, Hellen Kuasne, Chloé Apcher, Islam E. Elkholi, Marie-Anne Goyette, Proceedings of the National Academy of Sciences, 2021, 10.1073/pnas.2023868118
  • Hypoxia-inducible factor-1α stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion, Richard, D.E., Levine, M., Giaccia, A.J., Chan, D.A., Page, E.L., Molecular Biology of the Cell, 2008, 10.1091/mbc.E07-06-0612
  • A role for hypoxia-inducible factor-1 (HIF-1) in phosphate-induced vascular smooth muscle cell calcification, , Kidney International (In Press), 2016
  • Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation, Côté, J., Kutateladze, T.G., Yang, X.-J., Richard, D.E., Robitaille, G.A., Cayrou, C., Doyon, Y., Landry, A.-J., Glass, K.C., Paquet, E., Saksouk, N., Lalonde, M.-E., Avvakumov, N., Molecular and Cellular Biology, 2012, 10.1128/MCB.06455-11
  • p42/p44 mitogen-activated protein kinases phosphorylate hypoxia- reducible factor (HIF-1α) and enhance the transcriptional activity of HIF-1, Pouysségur, J., Roux, D., Gothié, E., Berra, E., Richard, D.E., Journal of Biological Chemistry, 1999, 10.1074/jbc.274.46.32631
  • Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1, Richard, D.E., Richard, S., Lafleur, V.N., Molecular Biology of the Cell, 2014, 10.1091/mbc.E13-07-0423
  • Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease, Agharazii, M., Richard, D.E., Mac-Way, F., St-Hilaire, J., Ung, R.-V., Gauthier-Bastien, A., Lariviere, R., Journal of Hypertension, 2017, 10.1097/HJH.0000000000001161
  • Signaling angiogenesis via p42/p44 MAP kinase cascade, Viñals, F., Richard, D.E., Pouysségur, J., Milanini, J., Pagès, G., Berra, E., Gothié, E., Annals of the New York Academy of Sciences, 2000
  • Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification, Richard, D.E., Agharazii, M., Cornfield, D.N., Gobeil, S., Lamalice, L., Larivière, R., Mokas, S., Kidney International, 2016, 10.1016/j.kint.2016.05.020
  • (2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors, Richard, D.E., Giaccia, A.J., Chan, D.A., Robitaille, G.A., Lauzier, M.-C., Molecular Pharmacology, 2008, 10.1124/mol.108.045690

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Depuis 2020/06
  • Rémi Riga - Maîtrise avec mémoire - En cours
  • Arielle Beaudoin - Maîtrise avec mémoire - En cours
  • Arianne Gervais - Maîtrise avec mémoire - En cours
  • Hadrien Benk-Fortin - Maîtrise avec mémoire - 2022/05

Encadrement d'étudiant(e)s

Direction de recherche dans les domaines suivants :

  • Biologie cellulaire et moléculaire
  • Sciences cliniques et biomédicales

En savoir plus sur les programmes

Disponibilité d'encadrement d'étudiant(e)s

Ce (cette) professeur(e) est présentement à la recherche d'étudiant(e)s.

Envoyer un courriel
*Les supervisions d’étudiant(e)s de 1er cycle en stage de recherche et de résident(e)s aux études médicales postdoctorales seront répertoriées ultérieurement.

Vice-décanat à la recherche et à l'innovation

Pavillon Ferdinand-Vandry
Université Laval
1050, avenue de la Médecine, local 4623
Québec (Québec) G1V 0A6
Canada

Renseignements - Secrétariat
418 656-2690
secretariatvdri@fmed.ulaval.ca

Jacques Simard
Vice-doyen à la recherche et à l'innovation
vice-doyen.recherche-et-innovation@fmed.ulaval.ca